To implement the new crown epidemic prevention and control requirements of the company firmly build employee health and safety "firewall"
Release time:
2021-12-23
News from our newspaper "The epidemic prevention and control requirements of government epidemic prevention departments at all levels must be strictly implemented; all kinds of internal epidemic prevention measures must be put in place without compromise." Since the beginning of winter, some areas of Zhejiang Province, the new coronary pneumonia epidemic, the company in the gold enterprise active action, in view of the actual to take strong epidemic prevention and control measures, for the health and safety of employees to build a reliable "firewall".
Recently, Ningbo, Shaoxing, Hangzhou have seen new crown pneumonia cases, Zhejiang Province epidemic prevention and control situation tends to be complex and severe, in order to prevent the spread of the epidemic to the surrounding areas, Zhejiang Province, Jinhua municipal government epidemic prevention departments have issued notices, the epidemic prevention and control requirements. After learning the epidemic information, the company's epidemic prevention and control work leading group immediately requested the gold enterprises to conduct a comprehensive investigation, will be within a certain period of time to have been to the relevant areas, with the relevant areas of personnel contact with the staff information in a timely manner to the epidemic prevention department and the community report, and take the corresponding epidemic emergency management measures. On the evening of
# August , Jinhua City held a video conference of the epidemic prevention and control leading group to deploy the epidemic prevention and control work. Ling Zhifeng, secretary of the municipal party committee, demanded that we should deeply understand the seriousness, complexity and urgency of the epidemic prevention and control situation, shift from the "peacetime" mode to the "wartime" mechanism, press and compact the responsibilities of all parties, do a good job in the prevention and control work with iron responsibility and iron discipline, and resolutely win the epidemic prevention and control war. 12 , Jinhua City new coronavirus pneumonia epidemic prevention and control work headquarters issued 43 work notice, put forward the system of prevention and control work requirements. In the early morning of Monday, 13 , the Group held a special working meeting on epidemic prevention and control to convey and implement the spirit of Circular 43 , reiterating the various prevention and control requirements since the outbreak of the new coronary pneumonia epidemic, but also making targeted deployments based on the characteristics of the current epidemic and the nature of the work of each enterprise. Jiang Xiaomeng, leader and chairman of the group's epidemic prevention and control work leading group, and Yu Jianhong, deputy leader and general manager, repeatedly stressed at the meeting that all gold units must attach importance to and understand the provincial and municipal epidemic prevention and control requirements, put all prevention and control work in place with high pressure, and conscientiously "close the door", strictly implement the "temperature measurement health code travel card
wearing masks" and registered personal information in place; Strengthen the publicity of epidemic prevention knowledge to employees and do a good job in daily killing in the region; Business contact is carried out by telephone and internet as far as possible. If it is really necessary to travel outside Jinhua city, it must be strictly reported and nucleic acid detection is carried out as required; check and arrange the vaccination status of employees, advocate less parties, less public places, abide by public order, and do a good job in personal health protection. ITC logistics, people flow, traffic flow intensive, peak pharmacy and extensive contact with the public, was identified as the company's recent epidemic prevention and control of the top priority. The meeting also asked enterprises to make necessary reserves of epidemic prevention materials for emergencies.After the meeting, the Company issued the "Notice on Further Doing a Good Job in the Prevention and Control of the New Crown Pneumonia Epidemic (2021 7
)". Detailed and specific requirements are put forward for the recent work of strengthening the screening of relevant regional residents, strengthening the daily epidemic prevention and control of workplaces throughout the Group, doing a good job in the prevention of epidemic risks in the movement and gathering of people, and strengthening the publicity of knowledge on the prevention and control of the new coronary pneumonia epidemic. In response to the new crown vaccine booster, which has received widespread attention in recent months, the notice specifically pointed out that employees who have completed two doses of the vaccine for more than six months should actively complete the third dose of vaccination on a voluntary basis to protect the health and safety of individuals and family members.12 April 14
, Chairman Jiang Xiaomeng, Deputy General Manager Xiang Chongping and relevant department personnel of the Group Company inspected the implementation of epidemic prevention and control work in gold enterprises, and put forward improvement measures for the deficiencies found in the inspection, requiring strict and prompt rectification.It is understood that at present, the company has actively implemented the epidemic prevention and control work in the gold enterprises, and according to the new characteristics of the current epidemic to strengthen the publicity of relevant knowledge; Group OA
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Contact Us
No. 88 Wujiang East Road, Jinhua City, Zhejiang Province, China
Tel: +86-579-82326868
Fax : +86-579-82324666
©2023 Zhejiang Jianfeng Group Co., Ltd. Powered by: www.300.cn SEO Business License
SAF Coolest v1.2 设置面板 SHJSS-AHDB-FSSQE-ZSW
无数据提示
Sorry, the current column has no content !
You can view other columns or return to Home Page